Literature DB >> 22618669

[Non-muscle invasive transitional cell carcinoma of the bladder. New developments in diagnostics and therapy].

M Sommerauer1, D Jocham, J M Laturnus.   

Abstract

Due to the high incidence and recurrence rate non-muscle invasive bladder cancer (NMIBC) has a relevant impact. Raman spectroscopy and optical coherence tomography represent innovative diagnostic tools. Urine markers still play a minor role in the diagnostics of NMIBC. New therapeutic options are thermochemotherapy and mitomycin-C electromotive drug administration (MMC-EMDA) as well as gemcitabine and apaziquone for intravesical administration.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22618669     DOI： 10.1007/s00120-012-2897-3

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  35 in total

1.  Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.

Authors:  Vinata B Lokeshwar; Tomonori Habuchi; H Barton Grossman; William M Murphy; Stefan H Hautmann; George P Hemstreet; Aldo V Bono; Robert H Getzenberg; Peter Goebell; Bernd J Schmitz-Dräger; Jack A Schalken; Yves Fradet; Michael Marberger; Edward Messing; Michael J Droller
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

Review 2.  Urine markers for detection and surveillance of non-muscle-invasive bladder cancer.

Authors:  Derya Tilki; Maximilian Burger; Guido Dalbagni; H Barton Grossman; Oliver W Hakenberg; Juan Palou; Oliver Reich; Morgan Rouprêt; Shahrokh F Shariat; Alexandre R Zlotta
Journal:  Eur Urol       Date:  2011-06-12       Impact factor: 20.096

3.  Optical biopsy in human urologic tissue using optical coherence tomography.

Authors:  G J Tearney; M E Brezinski; J F Southern; B E Bouma; S A Boppart; J G Fujimoto
Journal:  J Urol       Date:  1997-05       Impact factor: 7.450

Review 4.  Bladder cancer: epidemiology, diagnosis, and management.

Authors:  Chris Leo Pashos; Marc F Botteman; Benjamin Lewis Laskin; Alberto Redaelli
Journal:  Cancer Pract       Date:  2002 Nov-Dec

Review 5.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

6.  Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.

Authors:  Edwin Hungerhuber; Herbert Stepp; Martin Kriegmair; Christian Stief; Alfons Hofstetter; Arndt Hartmann; Ruth Knuechel; Alexander Karl; Stefan Tritschler; Dirk Zaak
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

7.  Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.

Authors:  Barbara Hermes; Felix Spöler; Amjad Naami; Jörg Bornemann; Michael Först; Joachim Grosse; Gerhard Jakse; Ruth Knüchel
Journal:  Urology       Date:  2008-05-02       Impact factor: 2.649

8.  Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.

Authors:  Jörg Schmidbauer; Fred Witjes; Nikolaus Schmeller; Roland Donat; Martin Susani; Michael Marberger
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

9.  Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC).

Authors:  Renzo Colombo; Andrea Salonia; Zvi Leib; Michele Pavone-Macaluso; Dov Engelstein
Journal:  BJU Int       Date:  2010-10-04       Impact factor: 5.588

10.  Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis.

Authors:  Colleen A Lingley-Papadopoulos; Murray H Loew; Michael J Manyak; Jason M Zara
Journal:  J Biomed Opt       Date:  2008 Mar-Apr       Impact factor: 3.170
View more
  2 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  [Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].

Authors:  G Gakis; B Volkmer; B Qvick; F Marteau; A Stenzl
Journal:  Urologe A       Date:  2019-01       Impact factor: 0.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.